Mon. May 25th, 2026
Spread the love

The Cambridge Boston Alignment Initiative (CBAI) Summer Research Fellowship in AI Safety 2026 is a prestigious, fully funded program designed for aspiring researchers who want to build impactful careers in artificial intelligence safety. Taking place in Cambridge, Massachusetts, this intensive nine-week fellowship runs from June 8 to August 10, 2026, offering participants the opportunity to work at the forefront of AI safety research.

About the Fellowship

The program brings together talented individuals to explore critical areas in AI safety, including:

  • Interpretability of AI systems
  • Multi-agent safety
  • Formal verification
  • Risk management frameworks
  • AI governance and policy

Fellows collaborate closely with experienced mentors and dedicated in-house research managers, gaining hands-on experience in tackling real-world AI safety challenges.

In addition to research work, participants engage in weekly workshops, speaker sessions, and community events, connecting with experts and peers across top institutions such as Harvard, MIT, Northeastern University, and leading AI safety organizations.

Fellowship Impact

The inaugural cohort has already demonstrated impressive outcomes, including:

  • Securing roles at leading AI safety organizations like Goodfire and Redwood
  • Publishing research accepted at top conferences such as NeurIPS and ICLR
  • Establishing independent research groups
  • Sharing policy-relevant insights with decision-makers in Washington, D.C.

This highlights the fellowship’s strong track record in launching successful AI safety careers.

What the Fellowship Offers

Participants will receive a comprehensive support package, including:

1. Generous Stipend

  • $10,000 provided over the nine-week program

2. Accommodation Support

  • Housing arranged for fellows coming from outside the Boston Metropolitan Area (via Harvard dorms or Airbnb)

3. Dedicated Workspace

  • 24/7 access to office space in Harvard Square, just minutes from Harvard Yard

4. Mentorship & Research Guidance

  • High-touch support from in-house research managers
  • Guidance to refine research direction and strengthen technical skills

5. Professional Development

  • Structured opportunities to enhance research capabilities and career growth

6. Networking Opportunities

  • Access to a vibrant AI safety community across top universities and organizations

7. Research Support

  • Resources and collaboration opportunities to produce impactful work

8. Extension Fellowship Opportunities

  • Potential pathways to continue research beyond the program.

 

Why You Should Apply

If you’re passionate about shaping the future of artificial intelligence and ensuring its safe development, this fellowship offers a rare chance to:

  • Gain hands-on research experience in AI safety
  • Work alongside leading experts in the field
  • Build a strong professional network
  • Accelerate your career in a rapidly growing and impactful domain

Application Deadline : April 12, 2026

METHOD OF APPLICATION

Interested and Qualified candidates should use link below to Apply.

CLICK HERE TO APPLY 

This fellowship is ideal for students, recent graduates, and early-career researchers who are committed to addressing some of the most pressing challenges in AI development and governance.

Discover more similar opportunities here. 

The post Apply Now: CBAI Summer AI Safety Fellowship 2026 in the USA $10,000 (Fully Funded) appeared first on Advert By Dotifi .Com Domains for almajiri.com.ng | Best African Hausa Music Blog, Entertainment ,News and Gossips .

By 9jabook

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.